Mutual Fund Ownership
Ownership as on: Mon, 4 Mar, 2024

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)3.50
% of AUM6.00%

Kotak Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)13.84
% of AUM5.51%

Tata India Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)36.43
% of AUM4.32%

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)23.77
% of AUM3.66%

ICICI Prudential Focused Equity Fund Growth

4/5
Equity
Amount Invested (Cr.)228.31
% of AUM3.35%

FAQs about Zydus Lifesciences share price

Zydus Lifesciences is trading at 946.10 as on Mon Mar 04 2024 10:16:27. This is 2.54% upper as compared to its previous closing price of 922.70.

The market capitalization of Zydus Lifesciences is 95745.32 Cr as on Mon Mar 04 2024 10:16:27.

The average broker rating on Zydus Lifesciences is Buy. The breakup of analyst rating is given below -

  • 6 analysts have given a strong buy rating
  • 7 analysts have given a buy rating
  • 10 analysts have given a hold rating
  • 3 analysts have given a sell rating
  • 2 analysts have given a strong sell rating

The 52 wk high for Zydus Lifesciences is 953.55 whereas the 52 wk low is 452.20

Zydus Lifesciences can be analyzed on the following key metrics -

  • TTM P/E: 23.57
  • Sector P/E: 21.77
  • Dividend Yield: 0.65%
  • D/E ratio: -

Zydus Lifesciences reported a net profit of 1960.30 Cr in 2023.

Recommended For You
Images
Trending Stocks
353.80+11.95(3.50%)
3,011.60+30.75(1.03%)
1,926.80-34.25 (-1.75%)
153.10-2.05 (-1.32%)